$CLPT 3 SEC Filings

Filed On	Filing
11 Oct 2022	Form 3: Sabra Mazin, Chief Operating Officer Holds 900 shares of Common Stock
19 May 2022	Form 3: Stigall L. Jeremy, GM, Biologics & Drug Delivery
03 Nov 2021	Form 3: Liau Linda M., Director No securities owned
16 Jul 2021	Form 3: Fallon Lynnette C, Director No securities owned
30 Sep 2020	Form 3: D'Alessandro Danilo, Vice President, Finance No securities owned
17 Apr 2020	Form 3: Klein Matthew B., Director Holds 0 shares of Common Stock
03 Sep 2019	Form 3: Johnson B Kristine, Director No securities owned
17 May 2019	Form 3: Souza Marcio, Director No securities owned
07 Nov 2017	Form 3: Burnett Joseph Michael, Director No securities owned
11 May 2017	Form 3: Fletcher R John, Director No securities owned
12 Sep 2016	Form 3: Voyager Therapeutics, Inc., 10% owner Holds 400,000 shares of Common Stock
31 Mar 2015	Form 3: Hurwitz Harold A, Vice President, Finance No securities owned
01 Dec 2014	Form 3: Maners Wendelin C, Vice President, Marketing No securities owned
06 Oct 2014	Form 3: Grillo Francis P, President No securities owned
03 Sep 2014	Form 3: Girin Pascal E R, Director No securities owned
10 Mar 2014	Form 3: Richards Timothy T., Director No securities owned
02 Jan 2014	Form 3: Sainz Maria, Director No securities owned
16 Apr 2013	Form 3: Pizzo Philip A., Director No securities owned
13 Nov 2012	Form 3: Korn Robert C., VP, Global Sales & Marketing No securities owned
27 Feb 2012	Form 3: Koob Charles E, Director Holds 20,000 shares of Common Stock

Comments